Your browser version may not work well with NCBI's Web applications. More information here...
1: Curr Control Trials Cardiovasc Med. 2000;1(2):83-87.Click here to read Click here to read Links

Results of the Ticlid or Plavix Post-Stents (TOPPS) trial: do they justify the switch from ticlopidine to clopidogrel after coronary stent placement?

Berger PB.

Mayo Clinic, Rochester, Minnesota, USA. berger.peter@mayo.edu

In the Ticlid or Plavix Post-Stents (TOPPS) trial, 1016 patients undergoing successful coronary stent placement were randomized to receive aspirin and either ticlopidine or clopidogrel. In this trial, the dosages and regimens of ticlopidine and clopidogrel resembled more closely those used in most catheterization laboratories than did the two previous randomized trials comparing ticlopidine and clopidogrel. The results of the TOPPS trial support the current practice of substituting ticlopidine for clopidogrel in stent patients.

PMID: 11714416 [PubMed - as supplied by publisher]

PMCID: PMC59605

Patient Drug Information